FAM
VRTX icon

Fortaleza Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Fortaleza Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,615
Closed -$398K – 144
2017
Q3 		$398K Buy
+2,615
New +$394K 0.73% 51
2015
Q3 		– Sell
-35
Closed -$4K – 212
2015
Q2 		$4K Hold
35
– – ﹤0.01% 165
2015
Q1 		$4K Hold
35
– – ﹤0.01% 182
2014
Q4 		$4K Hold
35
– – ﹤0.01% 192
2014
Q3 		$4K Buy
35
+5
+17% +$476 ﹤0.01% 210
2014
Q2 		$3K Sell
30
-20
-40% -$1.4K ﹤0.01% 200
2014
Q1 		$4K Hold
50
– – ﹤0.01% 191
2013
Q4 		$4K Buy
+50
New +$3.48K ﹤0.01% 185

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fortaleza Asset Management's VRTX Position: Q4 2017 in Review

Fortaleza Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2017, closing a stake of 2,615 shares — an estimated $398K sold.

Fortaleza Asset Management first reported a position in VRTX in Q4 2013 and held it in 8 quarters. The position peaked at $398K in Q3 2017. 644 funds tracked by Wall St. Rank hold VRTX as of Q4 2017.

  • Fortaleza Asset Management reported no remaining Vertex Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Fortaleza Asset Management sold 2,615 Vertex Pharmaceuticals shares in Q4 2017, an estimated $398K.
  • Fortaleza Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2013 and held it in 8 quarters.
  • Fortaleza Asset Management's Vertex Pharmaceuticals position peaked at $398K in Q3 2017.
  • 644 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2017.

Based on Fortaleza Asset Management's 13F filing for Q4 2017, filed 1 Feb 2018.